LEXARIA BIOSCIENCE CORP.

Profile

Company Names

LEXARIA BIOSCIENCE CORP.

Addresses

100 - 740 MCCURDY ROAD, KELOWNA, A1 V1X 2P7

156 VALLEYVIEW ROAD, KELOWNA, A1 V1X 3M4

SUITE 950, 1130 WEST PENDER STREET, VANCOUVER, A1 V6E 4A4

Phone Numbers

250-765-6424
604-602-1675

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, PHARMACEUTICALS, OTHER

Year Incorporated:

> 5 years ago

State Incorporated:

NEVADA

Total Amount Raised:

$22,549,644.00

Number of Funding Rounds:

14
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
14
2025-12-16 
$3,500,004.00 
$3,500,004.00 
$0.00 
 
13
2025-09-29 
$4,000,000.00 
$4,000,000.00 
$0.00 
 
12
2024-10-16 
$5,000,000.00 
$5,000,000.00 
$0.00 
 
11
2024-04-30 
$364,629.00 
$364,629.00 
$0.00 
 
10
2024-02-16 
$3,600,003.00 
$3,600,003.00 
$0.00 
 
9
2023-10-03 
$1,569,780.00 
$1,569,780.00 
$0.00 
 
8
2021-12-16 
$1,200,000.00 
$1,200,000.00 
$0.00 
Equity 
7
2021-07-27 
$85,000.00 
$85,000.00 
$0.00 
Equity 
6
2020-06-30 
$100,000.00 
$100,000.00 
$0.00 
Equity 
5
2020-05-06 
$2,039,228.00 
$2,039,228.00 
$0.00 
Equity 
4
2019-11-13 
$492,500.00 
$2,357,594.00 
$1,865,094.00 
Equity 
3
2019-11-05 
$180,000.00 
$180,000.00 
$0.00 
 
2
2018-10-31 
$310,000.00 
$310,000.00 
$0.00 
Equity 
1
2016-08-31 
$108,500.00 
$108,500.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
NICHOLAS 
 
BAXTER 
DIRECTOR
NICHOLAS 
W. 
BAXTER 
DIRECTOR
BAL 
 
BHULLAR 
DIRECTOR
CHRIS 
 
BUNKA 
EXECUTIVE OFFICER, DIRECTOR
CHRISTOPHER 
 
BUNKA 
EXECUTIVE OFFICER, DIRECTOR
NELSON 
 
CABATUAN 
EXECUTIVE OFFICER
RICHARD 
 
CHRISTOPHER 
EXECUTIVE OFFICER, DIRECTOR
JOHN 
 
DOCHERTY 
EXECUTIVE OFFICER, DIRECTOR
JOHN 
MARTIN 
DOCHERTY 
EXECUTIVE OFFICER, DIRECTOR
GREGORY 
 
DOWNEY 
EXECUTIVE OFFICER
TED 
 
MCKECHNIE 
DIRECTOR
WILLIAM 
EDWARD 
MCKECHNIE 
DIRECTOR
ALBERT 
 
REESE 
DIRECTOR
MICHAEL 
 
SHANKMAN 
EXECUTIVE OFFICER
ALLAN 
 
SPISSINGER 
EXECUTIVE OFFICER
CATHERINE 
 
TURKEL 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
$5,000,001 - $25,000,000 
 
2025-12-16 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
$5,000,001 - $25,000,000 
 
2025-09-29 
D
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
$5,000,001 - $25,000,000 
 
2024-10-16 
D
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
$1 - $1,000,000 
 
2024-04-30 
D
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
$1 - $1,000,000 
 
2024-02-16 
D
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
$1 - $1,000,000 
 
2023-10-03 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
$1 - $1,000,000 
Equity 
2021-12-16 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
$1 - $1,000,000 
Equity 
2021-07-27 
D
BIOTECHNOLOGY 
METAL MINING [1000] 
$1 - $1,000,000 
Equity 
2020-06-30 
D
OTHER 
METAL MINING [1000] 
DECLINE TO DISCLOSE 
Equity 
2020-05-06 
D
BIOTECHNOLOGY 
METAL MINING [1000] 
$1 - $1,000,000 
Equity 
2019-11-13 
D
BIOTECHNOLOGY 
METAL MINING [1000] 
$1 - $1,000,000 
 
2019-11-05 
D
PHARMACEUTICALS 
METAL MINING [1000] 
$1 - $1,000,000 
Equity 
2018-10-31 
D
PHARMACEUTICALS 
METAL MINING [1000] 
$1 - $1,000,000 
Equity 
2016-08-31 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
H.C. WAINWRIGHT + CO.
375
NONE
NONE
H.C. WAINWRIGHT + CO.
375
NONE
NONE
H.C. WAINWRIGHT + CO.
375
NONE
NONE
MAXIM GROUP LLC
NONE
NONE
BRADLEY WOODS + CO. LTD.